NG101m Adjuvant Therapy in Glioblastoma Patients
Phase 1
Not yet recruiting
- Conditions
- Glioblastoma Multiforme
- Interventions
- First Posted Date
- 2020-05-04
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- NeuGATE Theranostics
- Target Recruit Count
- 52
- Registration Number
- NCT04373785
- Locations
- 🇺🇸
Yvonne Kew MD, PLLC, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath